Literature DB >> 18178635

Diversity of the basic defect of homozygous CFTR mutation genotypes in humans.

F Stanke1, M Ballmann, I Bronsveld, T Dörk, S Gallati, U Laabs, N Derichs, M Ritzka, H-G Posselt, H K Harms, M Griese, H Blau, G Mastella, J Bijman, H Veeze, B Tümmler.   

Abstract

BACKGROUND: Knowledge of how CFTR mutations other than F508del translate into the basic defect in cystic fibrosis (CF) is scarce due to the low incidence of homozygous index cases.
METHODS: 17 individuals who are homozygous for deletions, missense, stop or splice site mutations in the CFTR gene were investigated for clinical symptoms of CF and assessed in CFTR function by sweat test, nasal potential difference and intestinal current measurement.
RESULTS: CFTR activity in sweat gland, upper airways and distal intestine was normal for homozygous carriers of G314E or L997F and in the range of F508del homozygotes for homozygous carriers of E92K, W1098L, R553X, R1162X, CFTRdele2(ins186) or CFTRdele2,3(21 kb). Homozygotes for M1101K, 1898+3 A-G or 3849+10 kb C-T were not consistent CF or non-CF in the three bioassays. 14 individuals exhibited some chloride conductance in the airways and/or in the intestine which was identified by the differential response to cAMP and DIDS as being caused by CFTR or at least two other chloride conductances. DISCUSSION: CFTR mutations may lead to unusual electrophysiological or clinical manifestations. In vivo and ex vivo functional assessment of CFTR function and in-depth clinical examination of the index cases are indicated to classify yet uncharacterised CFTR mutations as either disease-causing lesions, risk factors, modifiers or neutral variants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178635     DOI: 10.1136/jmg.2007.053561

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  10 in total

1.  Benign outcome among positive cystic fibrosis newborn screen children with non-CF-causing variants.

Authors:  Danieli Barino Salinas; Patrick R Sosnay; Colleen Azen; Suzanne Young; Karen S Raraigh; Thomas G Keens; Martin Kharrazi
Journal:  J Cyst Fibros       Date:  2015-03-29       Impact factor: 5.482

2.  Ubiquitination of disease-causing CFTR variants in a microsome-based assay.

Authors:  Samuel K Estabrooks; Jeffrey L Brodsky
Journal:  Anal Biochem       Date:  2020-07-01       Impact factor: 3.365

Review 3.  Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Chuan-Yun Li; Carlo Contoreggi; Judith Hess; Daniel Naiman; Qing-Rong Liu
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

4.  Assessing the Disease-Liability of Mutations in CFTR.

Authors:  Claude Ferec; Garry R Cutting
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

5.  Apparent homozygosity of a novel frame shift mutation in the CFTR gene because of a large deletion.

Authors:  Feras M Hantash; Arlene Rebuyon; Mei Peng; Joy B Redman; Weimin Sun; Charles M Strom
Journal:  J Mol Diagn       Date:  2009-03-26       Impact factor: 5.568

Review 6.  Addiction genetics and pleiotropic effects of common haplotypes that make polygenic contributions to vulnerability to substance dependence.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Qing-Rong Liu
Journal:  J Neurogenet       Date:  2009-01-19       Impact factor: 1.250

7.  Profile of cystic fibrosis in a single referral center in Egypt.

Authors:  Mona M El-Falaki; Walaa A Shahin; Noussa R El-Basha; Aliaa A Ali; Dina A Mehaney; Mona M El-Attar
Journal:  J Adv Res       Date:  2013-07-15       Impact factor: 10.479

8.  Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.

Authors:  W Joon Chung; Jennifer L Goeckeler-Fried; Viktoria Havasi; Annette Chiang; Steven M Rowe; Zackery E Plyler; Jeong S Hong; Marina Mazur; Gary A Piazza; Adam B Keeton; E Lucile White; Lynn Rasmussen; Allan M Weissman; R Aldrin Denny; Jeffrey L Brodsky; Eric J Sorscher
Journal:  PLoS One       Date:  2016-10-12       Impact factor: 3.240

9.  Rectal forceps biopsy procedure in cystic fibrosis: technical aspects and patients perspective for clinical trials feasibility.

Authors:  Maria F Servidoni; Marisa Sousa; Adriana M Vinagre; Silvia R Cardoso; Maria A Ribeiro; Luciana R Meirelles; Rita B de Carvalho; Karl Kunzelmann; Antônio F Ribeiro; José D Ribeiro; Margarida D Amaral
Journal:  BMC Gastroenterol       Date:  2013-05-20       Impact factor: 3.067

10.  Functional analysis of the p.[Arg74Trp;Val201Met;Asp1270Asn]/p.Phe508del CFTR mutation genotype in human native colon.

Authors:  Sylvia Schucht; Rebecca Minso; Christiane Lex; Jochen Reiss; Frauke Stanke; Stephanie Tamm; Andrea van Barneveld; Burkhard Tümmler
Journal:  Mol Genet Genomic Med       Date:  2019-01-01       Impact factor: 2.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.